Phase 1/2 Study of Amcenestrant (SAR439859) Single Agent and in Combination With Other Anti-cancer Therapies in Postmenopausal Women With Estrogen Receptor Positive Advanced Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Amcenestrant|DRUG: Palbociclib|DRUG: Alpelisib|DRUG: Everolimus|DRUG: Abemaciclib
Sponsor: Sanofi